Variant report
Variant | esv1010994 |
---|---|
Chromosome Location | chr11:93683241-93685525 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142009138 | chr11:93683286-93683287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542478886 | chr11:93683332-93683333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75216809 | chr11:93683346-93683347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532540862 | chr11:93683350-93683351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181469661 | chr11:93684001-93684002 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543904582 | chr11:93684047-93684048 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184699961 | chr11:93684083-93684084 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188621732 | chr11:93684084-93684085 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548040420 | chr11:93684170-93684171 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549849050 | chr11:93684187-93684188 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2511398 | chr11:93684809-93684810 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs151214920 | chr11:93684812-93684813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564304130 | chr11:93684847-93684848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2460057 | chr11:93684902-93684903 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs550261047 | chr11:93684938-93684939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568483610 | chr11:93684985-93684986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7942236 | chr11:93685031-93685032 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs908749 | chr11:93685035-93685036 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs566279867 | chr11:93685056-93685057 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201731770 | chr11:93685068-93685069 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139746131 | chr11:93685087-93685088 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558071078 | chr11:93685102-93685103 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145262999 | chr11:93685163-93685164 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536359469 | chr11:93685196-93685197 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555809480 | chr11:93685237-93685238 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574170304 | chr11:93685317-93685318 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577168934 | chr11:93685374-93685375 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201116454 | chr11:93685422-93685423 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201352889 | chr11:93685424-93685425 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs67487531 | chr11:93685425-93685426 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553341678 | chr11:93685436-93685437 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186997042 | chr11:93685472-93685473 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs67915626 | chr11:93685473-93685474 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs564138681 | chr11:93685499-93685500 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147612201 | chr11:93685519-93685520 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93681400-93683400 | Enhancers | HMEC | breast |
2 | chr11:93684000-93684200 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr11:93684800-93686400 | Enhancers | HepG2 | liver |
4 | chr11:93685000-93685800 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |